← Browse by Condition
Medical Condition

thrombocytopenia alloimmune

Total Trials
1
Recruiting Now
1
Trial Phases
EARLY_Phase 1
NCT06337474 EARLY_Phase 1
Recruiting

An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia

Enrollment
9 pts
Location
China
Sponsor
Changzhou No.2 People's Hospit...
View Trial →